Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,740,914
+$1,406,774 QoQ
Shares Held
22,814
+14.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1,234
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. ABBV ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,064 | $513,445 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,740,914 | 22,814 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,334,140 | 19,928 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,129,271 | 18,072 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $4,294,140 | 18,546 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $3,687,341 | 19,865 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $4,154,362 | 19,828 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $3,278,209 | 18,448 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $3,549,703 | 17,975 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $3,013,777 | 17,571 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,405,452 | 18,701 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,726,387 | 17,593 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,458,446 | 16,493 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,941,863 | 14,413 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,187,671 | 13,727 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,047,598 | 12,670 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $1,505,165 | 11,215 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,572,800 | 10,269 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,661,303 | 10,248 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,811,652 | 13,380 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,373,185 | 12,730 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,406,648 | 12,488 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,445,602 | 13,358 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,157,434 | 10,802 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $778,499 | 8,888 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $939,288 | 9,567 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $710,166 | 9,321 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||